Human Psychopharmacology-Clinical and Experimental

Papers
(The TQCC of Human Psychopharmacology-Clinical and Experimental is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The prevalence of constipation in adult psychiatric out‐patients on clozapine treatment at a regional public hospital in Hong Kong39
13
A Naturalistic Examination of the Acute Effects of High‐Potency Cannabis on Emotion Regulation Among Young Adults: A Pilot Study11
Evaluation of Depression, Anxiety, and Sleep Quality in Patients With Acne Vulgaris Receiving Isotretinoin Treatment11
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms11
Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers11
Bupropion and Anxiety: A Brief Review10
9
Becoming More Precise in Psychiatry: Signposts, Destinations, Maps and Territories8
Factors influencing concentrations of risperidone and 9‐hydroxyrisperidone in psychiatric outpatients taking immediate‐release formulations of risperidone8
Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report8
Effects of the active botanical blend “WKUP GT” on attention and cognitive functions after lunch in healthy volunteers7
7
Clinical Potential of Mirtazapine in Anxiety and Trauma‐Related Disorders: A Systematic Review and Meta‐Analysis of Current Evidence7
Effects of COVID‐19 Lockdowns on Alcohol Consumption, Hangovers and Smoking Among Young Adults ( n  = 140) in Germany: An On‐Line Study7
Efficacy and safety of hydroxyzine for sleep in adults: Systematic review6
Could R‐Ketamine and Wolfram Syndrome Inform Understanding of Depression and Suicidality? A Sigma‐1 Receptor‐Based Perspective6
Issue Information5
Hypothalamic‐pituitary‐adrenal and autonomic response to psychological stress in abstinent alcohol use disorder individuals with and without depressive symptomatology5
Issue Information5
Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia4
Issue Information4
Issue Information4
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant3
Comparison of Hip Fracture Risk Between Zolpidem and Zopiclone in Older Adults3
3
Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta‐analysis3
Nick Drake: A Troubled Mind, a Troublesome ‘Cure’3
Dexamphetamine increased speech and visual unimodal illusions in healthy participants without affecting temporal binding window3
Billy Mackenzie: Sometimes Wild, Often Lonely3
Facilitated extinction of conditioned fear responses by delta 9‐tetrahyrdrocannabidol in humans: a pilot study3
The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone3
Alcohol Consumption During the COVID‐19 Pandemic: A Critical Review3
Immunomodulatory Potential of Escitalopram on C‐C Motif Chemokine Ligand 5 and Fibroblast Growth Factor 2 in Patients With Generalised Anxiety Disorder3
Issue Information2
‘Nico’—A lone voyager in Strange Seas2
Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis2
National Prescribing Trends and Cost Analysis of Antidepressants, Anxiolytics, and Hypnotics in England, 2010–20232
Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey2
2
Exploring the understanding, source of availability and level of access of cognitive enhancers among university students in the United Arab Emirates: A qualitative study2
0.15927410125732